Rxcurve
HCPCS J0695 · per 75mg (50mg cft/25mg taz)

Inj ceftolozane tazobactam

Products billed under this code include Zerbaxa.

Payment limit per 75mg (50mg cft/25mg taz), by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0695

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Zerbaxa Merck Sharp & Dohme LLC 67919-0030-01 200 $2,003.00

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $10.015 −$0.023 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted September 17, 2026
3Q26 $10.038 +$1.202 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted September 15, 2026
2Q26 $8.836 −$0.111 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted September 15, 2026
1Q26 $8.947 −$0.119 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted September 15, 2026
4Q25 $9.066 −$0.062 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted September 8, 2026
3Q25 $9.128 +$1.087 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted March 10, 2026
2Q25 $8.041 −$0.108 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted March 10, 2026
1Q25 $8.149 −$0.081 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted December 19, 2025
4Q24 $8.23 −$0.011 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 11, 2025
3Q24 $8.241 +$0.952 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 11, 2025
2Q24 $7.289 −$0.081 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted March 11, 2025
1Q24 $7.37 −$0.111 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted December 19, 2024
4Q23 $7.481 −$0.059 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted October 10, 2024
3Q23 $7.54 +$0.826 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 5, 2024
2Q23 $6.714 +$0.158 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted February 23, 2024
1Q23 $6.556 +$0.205 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted December 6, 2023
4Q22 $6.351 −$0.044 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 22, 2023
3Q22 $6.395 −$0.003 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 9, 2023
2Q22 $6.398 −$0.239 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted December 14, 2022
1Q22 $6.637 $0.00 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 8, 2022
4Q21 $6.637 $0.00 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 2, 2022
3Q21 $6.637 +$0.28 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted June 2, 2022
2Q21 $6.357 −$0.07 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted March 1, 2022
1Q21 $6.427 – 75mg (50mg cft/25mg taz) Inj ceftolozane tazobactam v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files